Table 1

Main inclusion and exclusion criteria of the CONSUL study

Inclusion criteriaExclusion criteria
 Age ≥18 yearsPresence of total spinal ankylosis
 Definite diagnosis of AS according to the modified New York criteriaHistory of primary non-response to previous anti-TNF therapy (if any)
  Active disease (defined as BASDAI≥4)Contraindications for the treatment with golimumab and/or celecoxib
 History of an inadequate response to a therapeutic trials of at least two NSAIDs
 Risk factors for radiographic spinal progression (defined as elevated CRP or existing syndesmophytes) at screening
  • AS, ankylosing spondylitis; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; CRP, C reactive protein; NSAIDs, non-steroidal anti- inflammatory drugs; TNF, tumour necrosis factor.